Results 221 to 230 of about 936,810 (386)

Targeting P2X7 receptor inhibits the metastasis of murine P388D1 lymphoid neoplasm cells to lymph nodes

Cell Biology International, 2010
S. Ren, Yi Zhang, Yujing Wang, Y. Lui, Wei Wei, Xiaohua Huang, W. Mao, Y. Zuo   +7 more
semanticscholar   +1 more source

Early metastasis is characterized by Gr1+ cell dysregulation and is inhibited by immunomodulatory nanoparticles

Molecular Oncology, EarlyView.
Breast cancer metastasis is associated with myeloid cell dysregulation and the lung‐specific accumulation of tumor‐supportive Gr1+ cells. Gr1+ cells support metastasis, in part, through a CHI3L1‐mediated mechanism, which can be targeted and inhibited with cargo‐free, polymeric nanoparticles.
Jeffrey A. Ma, Sophia M. Orbach, Kate V. Griffin, Kathryn Kang, Yining Zhang, Rebecca S. Pereles, Ian A. Schrack, Guillermo Escalona, Jacqueline S. Jeruss, Lonnie D. Shea   +9 more
wiley   +1 more source

The preoperative blood lymphocyte-to-monocyte ratio acts as a superior prognostic factor and predicts tumor metastasis in gastric neuroendocrine neoplasms after surgery [PDF]

, 2017
Changming Huang, Long‐Long Cao, Chao‐Hui Zheng, Jian-Xian Lin, Jun Lü, Ping Li   +5 more
openalex   +1 more source

Skin Metastasis from a Parotid Neoplasm

, 2021
Eva Fuster Martín, Juan Jiménez, Rocio Solórzano Mariscal   +2 more
openalex   +1 more source

Evaluation of KRAS and NRAS mutations in metastatic colorectal cancer: an 8‐year study of 10 754 patients in Turkey

Molecular Oncology, EarlyView.
This nationwide study evaluated KRAS and NRAS mutations in 10 754 Turkish patients with metastatic colorectal cancer. The results revealed a mutation frequency of 51.1%, with 46.6% having KRAS mutations, 4.5% having NRAS mutations, and 48.5% being wild‐type for both.
Gozde Kavgaci, Izzet Akiva, Yavuz Hakan Ozon, Hakan Berkil, Huseyin Karadayi, Omer Dizdar, Suayib Yalcin   +6 more
wiley   +1 more source

Cutaneous metastasis as the first manifestation of neuroendocrine neoplasm of the lung: A case report

, 2021
Dragana Stojanović, Silvija Lučić, Andrea Péter, Dolores Srbovan, Olivera Ivanov, Aleksandra Lovrenski   +5 more
openalex   +2 more sources

Landscape of BRAF transcript variants in human cancer

Molecular Oncology, EarlyView.
We investigate the annotation of BRAF variants, focusing on protein‐coding BRAF‐220 (formerly BRAF‐reference) and BRAF‐204 (BRAF‐X1). The IsoWorm pipeline allows us to quantify these variants in human cancer, starting from RNA‐sequencing data. BRAF‐204 is more abundant than BRAF‐220 and impacts patient survival.
Maurizio S. Podda, Danilo Tatoni, Gianluca Mattei, Alberto Magi, Romina D'Aurizio, Laura Poliseno   +5 more
wiley   +1 more source

Loss of proton‐sensing GPR4 reduces tumor progression in mouse models of colon cancer

Molecular Oncology, EarlyView.
G protein‐coupled receptor 4 (GPR4) is a pH‐sensing receptor activated by acidic pH. GPR4 expression is increased in patients with inflammatory bowel disease who are at high risk of developing colorectal cancer. In mouse models, loss of GPR4 attenuated tumor progression. This correlated with increased IL2 and natural killer cell activity.
Leonie Perren, Moana Busch, Pedro A. Ruiz, Ermanno Malagola, Valeria Baumeler, Federica Foti, Adelina Gross, Tobias Grütter, Hendrik Edel, Cordelia Schuler, Kristina Handler, Glenn De Lange, Isabelle C. Arnold, Cheryl de Vallière, Klaus Seuwen, Martin Hausmann, Gerhard Rogler   +16 more
wiley   +1 more source

Development and validation of predictive models for distant metastasis and prognosis of gastroenteropancreatic neuroendocrine neoplasms [PDF]

Xiang Zhou, Lei Sun, Wenhao Liu, Xinyuan Song, Yang Gao, Jianpeng Xing, Shuohui Gao   +6 more
openalex   +1 more source

A Case of Tumor-to-Tumor Metastasis: Breast Carcinoma Metastatic to Oncocytic Carcinoma of Thyroid. [PDF]

Kans J Med
Gvazava N, Stevens TM, Rader RK.
europepmc   +1 more source